Genomic and related health data from Africa remain scarce and are extremely valuable, due to an abundance of variants often rare or absent in the rest of the world. Insights from such data will benefit global populations, but will Africa be neglected by limited access to affordable benefits resulting from research that uses their data?
No takes yet. Share an insight, caveat, or question.
Michèle Ramsay (2022) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: